PubRank

Luca Pierelli

Author PubWeight™ 24.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006 1.60
2 Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 2002 1.57
3 Regulated expression of MUC1 epithelial antigen in erythropoiesis. Br J Haematol 2003 1.56
4 Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 2001 1.40
5 A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel. Transfusion 2014 1.38
6 Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 2004 1.29
7 Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 2009 1.17
8 Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. Eur J Immunol 2012 0.99
9 Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures. J Transl Med 2010 0.93
10 Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol. Cytotherapy 2012 0.92
11 Total nucleated cells as a sole predictor of distinct targets of hematopoietic potential (CD34+ cells) in cord blood units: the results of a large series analysis in autologous cord blood units. Transfusion 2013 0.89
12 Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells. Transfusion 2007 0.88
13 Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15. J Immunol 2003 0.87
14 Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison. Transfusion 2012 0.87
15 Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications. Clin Cancer Res 2003 0.86
16 Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells. Exp Cell Res 2002 0.86
17 Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells. BMC Immunol 2009 0.85
18 Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion 2004 0.85
19 Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21. Leuk Lymphoma 2002 0.82
20 Optimization of the isolation and expansion method of human mediastinal-adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate. Cytotechnology 2013 0.82
21 Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria. Transfus Apher Sci 2012 0.81
22 The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. Fetal Diagn Ther 2003 0.80
23 A novel route of transplantation of human cord blood stem cells in preimmune fetal sheep: the intracelomic cavity. Stem Cells 2003 0.79
24 Biosimilar filgrastim (Zarzio(®)) vs. lenograstim (Myelostim(®)) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience. Leuk Lymphoma 2015 0.77
25 In vitro release and expansion of mesenchymal stem cells by a hyaluronic acid scaffold used in combination with bone marrow. Muscles Ligaments Tendons J 2013 0.75
26 Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with β-thalassaemia. Blood Transfus 2011 0.75
27 Integrated strategies for allogeneic blood saving in major elective surgery. Transfus Apher Sci 2011 0.75
28 Carboplatin-based neoadjuvant treatment with peripheral blood stem cell and growth factor support in locally advanced cervical cancer patients with bulky metastatic lymph nodes. Eur J Obstet Gynecol Reprod Biol 2006 0.75
29 Survey of current practice for monitoring and management of platelet refractoriness in Italy. Transfus Apher Sci 2012 0.75
30 Three missense mutations found in the KEL gene lead to K(mod) or K0 red blood cell phenotypes. Transfusion 2014 0.75
31 Cell cycle regulation in human hematopoietic stem cells: from isolation to activation. Leuk Lymphoma 2002 0.75